Publication | Closed Access

Dose-ranging evaluation of the antiemetic efficacy of intravenous dolasetron in patients receiving chemotherapy with doxorubicin or cyclophosphamide

Antiemetic EfficacyMedicineMetronomic TherapyPharmacologyIntravenous DolasetronPharmacotherapyMetronomic ChemotherapyCancer TreatmentOncologyRadiation OncologyDose-ranging Evaluation